Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myasthenia gravis: from autoantibodies to therapy.

Current opinion in neurology - 1 Oct 2018

Mantegazza Renato, Bernasconi Pia, Cavalcante Paola

Abstract excerpt

PURPOSE OF REVIEW: The current article reviews the recent advances in the field of myasthenia gravis, which span from autoantibody profiling and pathogenic mechanisms to therapy innovation. The overview is highlighting specifically the data and the needs of targeted treatments in the light of precision medicine in myasthenia gravis. RECENT FINDINGS: Novel data published recently further increased our knowledge on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmunity
Share to Autoantibodies
Share to Immunosuppressive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myasthenia Gravis

Share to Phenotype

Share to Precision Medicine

Source

Identifiers

PMID: 30156572
DOI: 10.1097/WCO.0000000000000596

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myasthenia gravis: from autoantibodies to therapy.PMID 30156572Read ↗

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read ↗

Clinical utility of autoantibodies in the diagnosis and management of Myasthenia gravisSemantic proximity Read ↗

Pathogenesis of myasthenia gravis: update on disease types, models, and mechanismsSemantic proximity Read ↗

The etiology of autoimmune diseases: the case of myasthenia gravis.Semantic proximity Read ↗

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

Myasthenia gravis and related disorders: Pathology and molecular pathogenesisSemantic proximity Read ↗

Distribution and Temporal Changes of Autoantibody-Mediated Pathogenic Mechanisms Among Acetylcholine Receptor-Positive Myasthenia Gravis PatientsSemantic proximity Read ↗

Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signatureSemantic proximity Read ↗

Myasthenia Gravis: paradox versus paradigm in autoimmunity.Semantic proximity Read ↗

The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.Semantic proximity Read ↗

Exploring Myasthenia Gravis Subtypes: Impact on Pregnancy and Recent Treatment AdvancementsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.